BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24378942)

  • 21. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
    Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
    Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Low A; Gavriilidis G; Larke N; B-Lajoie MR; Drouin O; Stover J; Muhe L; Easterbrook P
    Clin Infect Dis; 2016 Jun; 62(12):1595-1603. PubMed ID: 26951573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
    HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of opportunistic infections prior to HAART initiation does not affect immune reconstitution in HIV-infected patients.
    Pornprasert S; Traisathit P; Singboottra P; Huong NN
    Curr HIV Res; 2012 Oct; 10(7):592-6. PubMed ID: 22973852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
    Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
    Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia.
    Boettiger DC; Aurpibul L; Hudaya DM; Fong SM; Lumbiganon P; Saphonn V; Truong KH; Hansudewechakul R; Nguyen LV; Do VC; Bunupuradah T; Chokephaibulkit K; Nik Yusoff NK; Kumarasamy N; Wati DK; Razali KA; Kariminia A;
    Pediatr Infect Dis J; 2016 May; 35(5):e144-51. PubMed ID: 26835972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database.
    Hansudewechakul R; Sirisanthana V; Kurniati N; Puthanakit T; Lumbiganon P; Saphonn V; Yusoff NK; Kumarasamy N; Fong SM; Nallusamy R; Srasuebkul P; Law M; Sohn AH; Chokephaibulkit K;
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):503-9. PubMed ID: 20842043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.
    Bunupuradah T; Kariminia A; Chan KC; Ramautarsing R; Huy BV; Han N; Nallusamy R; Hansudewechakul R; Saphonn V; Sirisanthana V; Chokephaibulkit K; Kurniati N; Kumarasamy N; Yusoff NK; Razali K; Fong SM; Sohn AH; Lumbiganon P;
    Int J Infect Dis; 2013 Oct; 17(10):e806-10. PubMed ID: 23764352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and predictors of opportunistic infections in adolescents and adults after the initiation of antiretroviral therapy: A 10-year retrospective cohort study in Ethiopia.
    Woldegeorgis BZ; Diro CW; Yohannes B; Kerbo AA; Asgedom YS
    Front Public Health; 2022; 10():1064859. PubMed ID: 36589962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
    AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current scenario of opportunistic and co-infections in HIV-infected individuals at a tertiary care hospital in Mumbai, India.
    Chavan VR; Chaudhary V; Ahir P; Mehta R; Mavani PS; Kerkar C; Pramanik JM
    Indian J Med Microbiol; 2015; 33(1):78-83. PubMed ID: 25560006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing characteristics of a cohort of children and adolescents living with HIV at antiretroviral therapy initiation in Asia.
    Sornillo JB; Ditangco R; Kinikar A; Wati DK; Du QT; Nguyen DQ; Khol V; Nguyen LV; Puthanakit T; Ounchanum P; Kurniati N; Chokephaibulkit K; Jamal Mohamed TA; Sudjaritruk T; Fong SM; Kumarasamy N; Kosalaraksa P; Nallusamy RA; Nik Yusoff NK; Sohn AH; Kariminia A;
    PLoS One; 2023; 18(9):e0291523. PubMed ID: 37708128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia.
    Damtie D; Yismaw G; Woldeyohannes D; Anagaw B
    BMC Res Notes; 2013 Dec; 6():534. PubMed ID: 24330921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.